Icon

OPIPZA (NDA216655)- (2MG,5MG,10MG)

ARIPIPRAZOLE XIAMEN LP PHARM CO
2MG,5MG,10MG
No Yes
2041-Dec-15 Expired
None None
None No
OPIPZA is an atypical antipsychotic indicated for:  treatment of schizophrenia in patients ages 13 years and older  adjunctive treatment of major depressive disorder (MDD) in adults  irritability associated with autistic disorder in pediatric patients 6 years and older  treatment of Tourette’s disorder in pediatric patients 6 years and older
0 0 0
Total Other Developers None
Drugs with Suitability No
2MG ** ** - - -
5MG ** ** - - -
10MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.